2016
DOI: 10.1097/md.0000000000005592
|View full text |Cite
|
Sign up to set email alerts
|

Molecular characteristics of colorectal serrated polyps and hyperplastic polyps

Abstract: The serrated neoplasia pathway of colorectal carcinogenesis is characterized by BRAF mutation and aberrant DNA methylation, which have not been reported on Korean patients. The aim of this study was to investigate BRAF mutation and DNA methylation in colorectal serrated polyps and the right colon.Between 2005 and 2013, 146 colon polyps (47 tubular adenomas [TAs], 53 traditional serrated adenomas [TSAs], 17 sessile serrated adenomas/polyps [SSAs], and 29 hyperplastic polyps in the proximal colon [PHPs]) were co… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2018
2018
2020
2020

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 34 publications
0
2
0
Order By: Relevance
“…IGFBP7 has been shown to play a central role in BRAF-induced senescence and to be a direct target of TP53 [47]. Although methylation of IGFBP7 has been investigated in specific histological types of serrated lesions [10,48], IGFBP7 methylation status has not been compared between these two TSA subtypes. In addition to these differences in genetic and epigenetic alterations, the difference in the prevalence of β-catenin expression further supports there being two different neoplastic pathways for TSAs.…”
Section: Discussionmentioning
confidence: 99%
“…IGFBP7 has been shown to play a central role in BRAF-induced senescence and to be a direct target of TP53 [47]. Although methylation of IGFBP7 has been investigated in specific histological types of serrated lesions [10,48], IGFBP7 methylation status has not been compared between these two TSA subtypes. In addition to these differences in genetic and epigenetic alterations, the difference in the prevalence of β-catenin expression further supports there being two different neoplastic pathways for TSAs.…”
Section: Discussionmentioning
confidence: 99%
“…MLH1 warrants separate discussion as its role in SSA progression is well established. Previous studies have demonstrated MLH1 methylation is detectable in otherwise unremarkable SSAs, ranging from 0.0 to 89.5% [13, 28, 31, 32, 5465]. The cause for this large variation is uncertain but has been attributed to patient ethnicity [58], patient age [13, 60], lesion site [31, 55, 58] and primer choice [58, 66].…”
Section: Discussionmentioning
confidence: 99%